Bolni Marius Nagalo

Federal Grant PI

Associate Professor

University of Arkansas for Medical Sciences

faculty

bolnimarius@gmail.com

18 h-index 89 pubs 1,079 cited

Research Areas

Cancer Treatment and Pharmacology Immune Response and Inflammation Pharmacological Effects and Toxicity Studies Cancer-related molecular mechanisms research Microbial infections and disease research Phytochemicals and Antioxidant Activities Cancer Immunotherapy and Biomarkers

Links

ORCID Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Bolni Marius Nagalo's research focuses on understanding and targeting complex biological processes, particularly in the context of cancer and inflammatory diseases. He has investigated the therapeutic potential of natural compounds like fisetin to alleviate skin inflammation by dual targeting of mTOR/IL-17A and autophagy. His work also explores the tumor microenvironment as a significant barrier and target in pancreatic cancer. Additionally, Dr. Nagalo has examined the role of cell-free tumor DNA allele frequency in predicting outcomes for advanced biliary cancers treated with platinum-based chemotherapy and the synergistic effects of combining cytotoxic chemotherapy with cyclin-dependent kinase 4/6 inhibitors in these cancers. His research interests extend to immunovirotherapy utilizing recombinant vesicular stomatitis virus and vaccine-related immune responses, as indicated by his publication on ChAdOx1's interaction with CAR and PF4 and its implications for thrombosis with thrombocytopenia syndrome. He has also contributed to studies on blood-borne infections among blood donors in Burkina Faso.

Metrics

  • h-index: 18
  • Publications: 89
  • Citations: 1,079

Selected Publications

  • The impact of the timing of adjuvant treatment initiation in patients with upfront resection of pancreatic cancer (2025) DOI
  • Monensin and Its Analogs Exhibit Activity Against Breast Cancer Stem-Like Cells in an Organoid Model (2025) DOI
  • Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening (2025) DOI
  • Monensin and Its Analogs Offer a Multi-Targeted Approach to Enhancing Metastatic Breast Cancer Immunogenicity and Cell Death (Abstract ID: 163059) (2025) DOI
  • 474 Repositioning monensin: Enhancing anti-cancer activity and immune modulation in breast cancer cells (2025) DOI
  • Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade (2024) DOI
  • Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics (Adv. Mater. 45/2024) (2024) DOI
  • Abstract B049: Oncolytic virotherapy as an effective tool to synergistically enhance therapeutic efficacy of standard systemic treatments for pancreatic cancer (2024) DOI
  • Percutaneous Delivery of Oncogel for Targeted Liver Tumor Ablation and Controlled Release of Therapeutics (2024) DOI
  • Spontaneous regression of advanced hepatocellular carcinoma following COVID-19 infection and vaccination: a case report and review of literature (2024) DOI
  • Enhancing Neoadjuvant Virotherapy’s Effectiveness by Targeting Stroma to Improve Resectability in Pancreatic Cancer (2024) DOI
  • Assessing the Diagnostic Potential of Hemoglobin-Platelet and Lymphocyte- Monocyte Ratios for Colorectal Cancer (2024) DOI
  • The Africa hepatopancreatobiliary cancer consortium for the study of epidemiology, etiology, pathobiology of liver, biliary tract, and pancreatic cancers in Africa (2024) DOI
  • Monensin and its derivatives increase MHC Class I and II presentations in breast cancer (2024) DOI
  • Abstract 588: Preclinical evaluation of novel chimeric vesiculovirus mediated expression of proteolytic enzymes targeting two major stromal components of pancreatic ductal adenocarcinoma (2024) DOI

Collaborators

Researchers in the database who share publications

Steven R. Post University of Arkansas for Medical Sciences 12 shared publications Mulu Z. Tesfay University of Arkansas for Medical Sciences 9 shared publications Camila Simões University of Arkansas for Medical Sciences 9 shared publications Martin J. Cannon University of Arkansas for Medical Sciences 8 shared publications Alexei G. Basnakian Arkansas State University 8 shared publications Khandoker Usran Ferdous University of Arkansas for Medical Sciences 8 shared publications Alicja Urbaniak University of Arkansas for Medical Sciences 5 shared publications Thomas J. Kelly University of Arkansas for Medical Sciences 4 shared publications

Similar Researchers

Based on overlapping research topics

Alena V. Savenka National Center for Toxicological Research
Cancer Treatment and Pharmacology Immune Response and Inflammation Pharmacological Effects and Toxicity Studies
Strong match 6 shared topics
Robert Griffin University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Immune Response and Inflammation Pharmacological Effects and Toxicity Studies
Good match 5 shared topics
D Heinrichs University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology Immune Response and Inflammation Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
A. Mazin Safar University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Immune Response and Inflammation Cancer-related molecular mechanisms research
Good match 4 shared topics
Mousumi Patra University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Immune Response and Inflammation Pharmacological Effects and Toxicity Studies
Good match 5 shared topics
Lauren C. Morehead University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Immune Response and Inflammation Cancer-related molecular mechanisms research
Good match 4 shared topics